Pharmadrug Inc.
LMLLF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $1 | $3 | $5 | $13 |
| - Cash | $0 | $0 | $0 | $1 |
| + Debt | $1 | $2 | $1 | $1 |
| Enterprise Value | $2 | $4 | $7 | $13 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | -100% | – |
| Gross Profit | $0 | -$0 | -$0 | -$0 |
| % Margin | – | – | – | -30.7% |
| EBITDA | -$1 | -$1 | -$2 | -$4 |
| % Margin | – | – | – | -60,037.1% |
| Net Income | -$1 | -$13 | -$9 | -$6 |
| % Margin | – | – | – | -83,806.5% |
| EPS Diluted | -0.008 | -0.23 | -0.061 | -0.12 |
| % Growth | 96.7% | -275.8% | 49% | – |
| Operating Cash Flow | -$1 | -$1 | -$2 | -$4 |
| Capital Expenditures | -$0 | $0 | $0 | -$0 |
| Free Cash Flow | -$1 | -$1 | -$2 | -$4 |